The science sector could be missing out on unlocking Neurodiverse potential by not knowing about this UK Government scheme
Companies in the science sector in the Cambridge area could be missing out on unlocking latent strengths of neurodiverse employees because they either don't know about or avoid using the UK Government's Access To Work Scheme.
UK proteostasis community comes together for a successful inaugural event
The UK’s proteostasis community came together for the first event of the UK Proteostasis Network at the Institute.
PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders
New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics
Deloitte Cambridge opens new business lounge
The Life Sciences Catalyst Business Lounge, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, has been opened by Deloitte Cambridge.
Controlling pediatric Asthma symptoms
Asthma, a common childhood respiratory disease involving both airway inflammation and impaired airflow. Asthma places a tremendous pressure on health systems across the globe [1]. It is estimated that one in eleven children in the UK are currently being prescribed treatment for asthma.
AT278 ultra-concentrated ultra-rapid acting insulin demonstrates superiority in Phase I Clinical Trial in overweight and obese people with type 2 diabetes
AT278 demonstrates significantly accelerated PK/PD profile compared to NovoRapid® and Humulin® R U-500 in people with Type 2 Diabetes and high BMI
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering
How Meaningful Work Drives Employee Motivation
For many people, the pursuit of purpose and meaning has become a driving force behind employee motivation and engagement.
New TV series sees surgeon carry out complex facial surgery after e-scooter incident
A leading Addenbrooke’s surgeon performed a complex operation following an e-scooter incident, in a powerful new TV series on treatments to the face, neck and head.
Cambridge Science Centre announces AstraZeneca’s valued and continuing support for the coming year
Cambridge Science Centre, a Cambridge-based charity dedicated to fostering curiosity and learning in Science, Technology, Engineering, and Mathematics (STEM) among children, is thrilled to announce the renewal of its partnership with AstraZeneca for the upcoming year.
Activotec launches new Activo-Darwin peptide synthesizer
Cambridge, UK, May 4th, 2024: Activotec Ltd announces the launch of its Activo-Darwin Semi-Automated Peptide Synthesizer, a cutting-edge instrument designed for the synthesis of very high quality peptides.
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic
Proof-of-Concept study to investigate personalized dose management of first-line anti-hypertensive in improving blood pressure control remotely Key milestone in co-development partnership to combine leading medicine brands with dose optimization technologyAnna Gaetani joins Salus Wellness
Salus Wellness writes...we are happy to announce that Anna Gaetani has joined Salus Wellness this month. Anna is a qualified Level 3 Sport Massage Therapist, specializing in both sport and relaxing massages for adults affected by muscle tension, muscle and joint pain and general need for relaxing treatment.
Life saving medical product design
The latest lifesaving statistics for the EndoCuff Vision® are compelling and now show that 5 million have been sold, with 49,000 colon cancers prevented and over 9,500 lives saved. DesignEdge helped design and innovate this medical device to improve the colonoscopy procedure.
Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer
Cambridge, UK: Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, announces the appointment of Hazel Jones as Chief Executive Officer, after a successful six-month tenur
Over 20,000 people join search for new dementia treatments
Volunteers at the BioResource have contributed to a study that aims to speed up the development of much-needed dementia drugs. Our Genes & Cognition cohort will enable scientists in universities and industry to involve healthy individuals in clinical trials to test whether new drugs can slow the decline in various brain functions including memory and delay the onset of dementia.
Optibrium partners with FMC Corporation to transform agrochemical discovery
Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline.
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec
Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
The socioeconomic impact of Multiple Sclerosis (MS) extends to various areas of a patient’s life including personal wellbeing and mental health, family life and planning, employment and the lives of caregivers, which is associated with a significant economic and societal burden.
Cream of Cambridge science showcase tomorrow’s innovations at Cambridge Wide Open Day
The Cambridge Wide Open Day event is a unique opportunity for all to find out firsthand about the game-changing scientific advancements and technological innovations happening right here in our city, the UK’s science and tech capital.
Guardtech elevate rapid cleanroom offering as new era of Isopod takes shape
Suffolk-based cleanroom construction experts back up new website with a string of exciting developments for the quick-assembly brand
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Led by Voima Ventures and co-led by existing investor Eir Ventures Funding will support continued development of Auga sensor system platform to accelerate the bioprocessing workflow from early upstream to late formulationStockholm, Sweden
ERS Genomics appoints John E Milad as Chief Executive Officer
Dublin, Ireland: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announces the appointment of John E Milad as CEO, with immediate effect.
Celebrating Research Nurses on International Nurses Day 2024
Each year, on 12 May, International Nurses Day highlights the fantastic work carried out by nurses worldwide. It is an opportunity to demonstrate the remarkable difference that nursing staff make to many lives. Here at the BioResource, our Research Nurses are at the forefront of recruiting volunteers to participate in health research. Find out about what their vital role entails and hear from…
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
Medtronic to fund Arecor’s development of Arestat™ enabled novel, high concentration, thermostable insulin, specifically tailored for use in combination with a next-generation implantable pump